Perlmutter Cancer Center
Research Assistant Professor, Department of Medicine
My research is focused on creating proteins with novel functions for therapy and basic science applications. I have made important contribution to the development of technologies that have made it possible to create synthetic binding proteins from inert protein scaffolds. I am an expert of designing and constructing large combinatorial libraries in the phage- and yeast-display systems. Using these technologies, I have developed potent and selective binding proteins, both antibody and non-antibody molecules, against diverse targets. These novel molecules have enabled numerous collaborative investigations in which we elucidated structures and molecular mechanisms of biomedically important proteins and revealed novel approaches to controlling them.
My colleagues and I are further advancing our protein engineering technologies with a particular emphasis on developing therapeutic strategies against currently “undruggable” cancer drivers.
646-501-4602
522 1st ave, Smilow 1107
11, 1107
New York, NY 10016
Research Assistant Professor, Department of Medicine at NYU Grossman School of Medicine
PhD from University of Tokyo
Proceedings of the National Academy of Sciences of the United States of America (PNAS). 2025 Jan 07; 122(1):e2411720121
Nature communications. 2024 Dec 23; 15(1):10724
Oncogene. 2024 Nov; 43(48):3489-3497
Nature chemical biology. 2024 Oct 22;
Cell communication & signaling : CCS. 2024 Oct 16; 22(1):500
Proceedings of the National Academy of Sciences of the United States of America (PNAS). 2024 May 28; 121(22):e2319029121
Nature communications. 2024 May 27; 15(1):4494
Cold Spring Harbor protocols. 2024 May 02; 2024(5):pdb.over107982